Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Health Insurance / Medical Insurance News

Health Companies' Momentum May Cut Right Through Reform Savings

Main Category: Health Insurance / Medical Insurance
Also Included In: Pharma Industry / Biotech Industry;  Medicare / Medicaid / SCHIP
Article Date: 26 Nov 2009 - 4:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Health companies have done better than the rest of corporate America during the past decade, MarketWatch/Seattle Times reports. While profits at the S&P 500 companies declined slightly over 10 years, "[d]ata compiled by MarketWatch show that the 52 health-care companies in the index are about to close out the decade with average profits that nearly tripled." Despite Congress' efforts to overhaul the health system, analysts say "that level of moneymaking seems unlikely to change anytime soon" because "there just aren't many reform proposals that would take a significant bite out of health-care profits (Britt, 11/25).

With that in mind, lawmakers have been eyeing the pharmaceutical industry, PharmExec reports. "Congressional leaders clearly believe that pharmaceutical companies can afford to contribute more than $80 billion [already committed] to support health reform … [in part because] the boost in coverage to some 40 million potential customers is a 'sweetheart deal' that will increase sales more than enough to cover those losses." House Democrats are considering a bill that could allow the government to negotiate for Medicare drug prices for the first time, costing the industry another $40 billion over 10 years (Wechsler, 11/24).

Meanwhile, new research suggests another possible pricing controversy. "Medicaid pharmacy costs for the blood-thinning drug Plavix jumped at around the same time the drug's maker started advertising it to consumers -- even though the number of people prescribed the drug didn't change," a study in the Archives of Internal Medicine suggests, ABC News reports (Harding, 11/24).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.



View drug information on PLAVIX.





Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
Senate Passes COBRA Extension
21 Dec 2009
When the Senate passed a $626 billion defense spending measure Saturday morning, it was good news for laid-off workers who get the COBRA subsidy. The Detroit Free Press: "The congressional stimulus bill passed in...


Coping with the Holiday Blues
Coping with the Holiday Blues

For many people, the holidays are a time of stress and sadness. Psychologist Dr. Carol Goldberg explores why and offers tips on how to avoid the holiday blues.

more videos are available in our health videos section.